28th May 2019. In acknowledgement of International Clinical Trials Day, MSD wants to say thank you to the 500 MSD clinical trial patients around the country.1 MSD New Zealand Director, Paul Smith says, “MSD is one of the few pharmaceutical companies undertaking...
ETHERAL Europe Reached 100 Patients Randomized Last Week MADRID, SPAIN and CAMBRIDGE, MA / ACCESSWIRE / May 29, 2019 / Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in...
As the leader in Advanced Diagnostics, including Next Generation Sequencing (NGS), Quest joins a select group of commercial and academic laboratories to meet the rigorous requirements for participation in this clinical trial Both the Quest Med Fusion 50SEQ cancer...
First major double-blind trial of cannabidiol (CBD) remedies for dogs Therabis “Mobility” to be studied for its effectiveness in treating osteoarthritic pain Researchers seeking treatment options for the joint mobility issues affecting more than 50% of...
Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), the largest cardio-cerebral vascular (“CCV”) drug manufacturer in China’s prescription drug market, announced the third generation of EGFR inhibitor XZP-5809, a Category 1 innovative drug...
Ansun Biopharma, Inc., today announced that the first patient has been enrolled in its Phase 3 clinical trial evaluating the efficacy and safety of DAS181 for the treatment of hospitalized, immunocompromised patients with lower respiratory tract parainfluenza virus...
Email
Text